Yu, Su-Yeon; Yang, Bong-Min; Kim, Jin-Hyun - In: Applied Health Economics and Health Policy 11 (2013) 4, pp. 311-318
The South Korean Government recently announced a reform in the drug anti-rebate law, with the purpose of eradicating pervasive, unethical, and illegal rebate practices in pharmaceutical marketing. The main objective of this reform is to have the ability to bring criminal charges against doctors...